Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines
暂无分享,去创建一个
M. Bachmann | P. Saudan | G. Cabral-Miranda | V. Manolova | Aadil Turabi | F. Zabel | A. Flace | A. Gomes
[1] R. Kedl,et al. T Cell Vaccinology: Beyond the Reflection of Infectious Responses. , 2016, Trends in immunology.
[2] K. Legge,et al. Protective CD8 T Cell–Mediated Immunity against Influenza A Virus Infection following Influenza Virus–like Particle Vaccination , 2013, The Journal of Immunology.
[3] T. Kündig,et al. Virus-induced humoral immunity: on how B cell responses are initiated. , 2013, Current opinion in virology.
[4] R. Coffman,et al. Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. , 2011, Immunity.
[5] Z. Su,et al. Particle size affects the cellular response in macrophages. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[6] Martin F. Bachmann,et al. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns , 2010, Nature Reviews Immunology.
[7] P. Alves,et al. Virus-like particles in vaccine development , 2010, Expert review of vaccines.
[8] G. Jennings,et al. A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice , 2010, Virology Journal.
[9] I. Štěpánek,et al. Induction of protective immunity against MHC class I-deficient, HPV16-associated tumours with peptide and dendritic cell-based vaccines. , 2010, International journal of oncology.
[10] K. Schwarz,et al. Innate signaling regulates cross‐priming at the level of DC licensing and not antigen presentation , 2009, European journal of immunology.
[11] M. Albert,et al. Orchestration of the immune response by dendritic cells , 2009, Current Biology.
[12] F. Batista,et al. BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation. , 2009, Blood.
[13] María López-Bravo,et al. Review in Vivo Induction of Immune Responses to Pathogens by Conventional Dendritic Cells , 2022 .
[14] Gabrielle T Belz,et al. Dendritic cells: driving the differentiation programme of T cells in viral infections , 2008, Immunology and cell biology.
[15] Katrin Schwarz,et al. Nanoparticles target distinct dendritic cell populations according to their size , 2008, European journal of immunology.
[16] Sai T Reddy,et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines , 2007, Nature Biotechnology.
[17] A. Jegerlehner,et al. TLR9 Signaling in B Cells Determines Class Switch Recombination to IgG2a , 2007, The Journal of Immunology.
[18] A. Krieg,et al. Therapeutic potential of Toll-like receptor 9 activation , 2006, Nature Reviews Drug Discovery.
[19] K. Schwarz,et al. Efficient homologous prime‐boost strategies for T cell vaccination based on virus‐like particles , 2005, European journal of immunology.
[20] Jie Li,et al. Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors1 , 2004, The Journal of Immunology.
[21] M. Garcia-Alai,et al. The HPV16 E7 viral oncoprotein self-assembles into defined spherical oligomers. , 2004, Biochemistry.
[22] K. Schwarz,et al. Nonmethylated CG Motifs Packaged into Virus-Like Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects , 2004, The Journal of Immunology.
[23] R. Zinkernagel. On natural and artificial vaccinations. , 2003, Annual review of immunology.
[24] Antonio Lanzavecchia,et al. Regulation of Dendritic Cell Migration to the Draining Lymph Node , 2003, The Journal of experimental medicine.
[25] R. Zinkernagel,et al. T helper cell‐independent neutralizing B cell response against vesicular stomatitis virus: Role of antigen patterns in B cell induction? , 1995, European journal of immunology.
[26] P. Pumpens,et al. Recombinant RNA phage Q beta capsid particles synthesized and self-assembled in Escherichia coli. , 1993, Gene.
[27] A. Matus,et al. A novel strategy for the immunological tagging of cDNA constructs. , 1993, Gene.
[28] J L Grun,et al. Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses. , 1989, Cellular immunology.
[29] H. Will,et al. Expression of the hepatitis B virus core gene in vitro and in vivo , 1987, Journal of virology.
[30] B. Vogelstein,et al. Molecular determinants of immunogenicity: the immunon model of immune response. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[31] John D Lambris,et al. Crossroads Between Innate and Adaptive Immunity V , 2015, Advances in Experimental Medicine and Biology.
[32] R. Jia,et al. The effect of antigen size on the immunogenicity of antigen presenting cell targeted DNA vaccine. , 2012, International immunopharmacology.
[33] John D Lambris,et al. Crossroads Between Innate and Adaptive Immunity IV , 2013, Advances in Experimental Medicine and Biology.
[34] C. Janeway,et al. Innate immune recognition. , 2002, Annual review of immunology.